184 related articles for article (PubMed ID: 22363300)
1. A Medicinal Herb Scutellaria lateriflora Inhibits PrP Replication in vitro and Delays the Onset of Prion Disease in Mice.
Eiden M; Leidel F; Strohmeier B; Fast C; Groschup MH
Front Psychiatry; 2012; 3():9. PubMed ID: 22363300
[TBL] [Abstract][Full Text] [Related]
2. Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
Thellung S; Corsaro A; Dellacasagrande I; Nizzari M; Zambito M; Florio T
Front Neurosci; 2022; 16():966019. PubMed ID: 36148145
[TBL] [Abstract][Full Text] [Related]
3. Anti-oxidative and DNA protecting effects of flavonoids-rich Scutellaria lateriflora.
Lohani M; Ahuja M; Buabeid MA; Dean S; Dennis S; Suppiramaniam V; Kemppainen B; Dhanasekaran M
Nat Prod Commun; 2013 Oct; 8(10):1415-8. PubMed ID: 24354189
[TBL] [Abstract][Full Text] [Related]
4. Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches.
Ferreira NC; Marques IA; Conceição WA; Macedo B; Machado CS; Mascarello A; Chiaradia-Delatorre LD; Yunes RA; Nunes RJ; Hughson AG; Raymond LD; Pascutti PG; Caughey B; Cordeiro Y
PLoS One; 2014; 9(1):e84531. PubMed ID: 24400098
[TBL] [Abstract][Full Text] [Related]
5.
Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
[TBL] [Abstract][Full Text] [Related]
6. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products.
Kocisko DA; Baron GS; Rubenstein R; Chen J; Kuizon S; Caughey B
J Virol; 2003 Oct; 77(19):10288-94. PubMed ID: 12970413
[TBL] [Abstract][Full Text] [Related]
7. What is the role of lipids in prion conversion and disease?
Alves Conceição C; Assis de Lemos G; Barros CA; Vieira TCRG
Front Mol Neurosci; 2022; 15():1032541. PubMed ID: 36704327
[TBL] [Abstract][Full Text] [Related]
8. Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.
Charco JM; Eraña H; Venegas V; García-Martínez S; López-Moreno R; González-Miranda E; Pérez-Castro MÁ; Castilla J
Pathogens; 2017 Dec; 6(4):. PubMed ID: 29240682
[TBL] [Abstract][Full Text] [Related]
9. Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.
Toni M; Massimino ML; De Mario A; Angiulli E; Spisni E
Front Neurosci; 2017; 11():3. PubMed ID: 28154522
[TBL] [Abstract][Full Text] [Related]
10. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of flavonoid biosynthetic genes and accumulation of baicalin, baicalein, and wogonin in plant and hairy root of
Tuan PA; Kim YS; Kim Y; Thwe AA; Li X; Park CH; Lee SY; Park SU
Saudi J Biol Sci; 2018 Dec; 25(8):1639-1647. PubMed ID: 30591781
[No Abstract] [Full Text] [Related]
12. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
13. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.
Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B
Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063
[TBL] [Abstract][Full Text] [Related]
14. A novel generation of heparan sulfate mimetics for the treatment of prion diseases.
Adjou KT; Simoneau S; Salès N; Lamoury F; Dormont D; Papy-Garcia D; Barritault D; Deslys JP; Lasmézas CI
J Gen Virol; 2003 Sep; 84(Pt 9):2595-2603. PubMed ID: 12917481
[TBL] [Abstract][Full Text] [Related]
15. New approaches for the selection and evaluation of anti-prion organic compounds.
Cordeiro Y; Ferreira NC
Mini Rev Med Chem; 2015; 15(2):84-92. PubMed ID: 25723455
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of Animal Prion Diseases.
Orge L; Lima C; Machado C; Tavares P; Mendonça P; Carvalho P; Silva J; Pinto ML; Bastos E; Pereira JC; Gonçalves-Anjo N; Gama A; Esteves A; Alves A; Matos AC; Seixas F; Silva F; Pires I; Figueira L; Vieira-Pinto M; Sargo R; Pires MDA
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801117
[TBL] [Abstract][Full Text] [Related]
17. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
18. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the major flavonoid content of S. baicalensis, S. lateriflora, and their commercial products.
Makino T; Hishida A; Goda Y; Mizukami H
J Nat Med; 2008 Jul; 62(3):294-9. PubMed ID: 18404307
[TBL] [Abstract][Full Text] [Related]
20. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
